🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Inflamatory Bowel Disease

A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab NCT07487480n/a1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Observation Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease NCT07533890NA1 site📍 Bern Insel Gruppe AG, University Hospital Bern · Tests: Probiotic Formula, Observation Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD) NCT07593352n/a1 site📍 Warsaw Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych… · Tests: Prospective assessment of the prevalence of kidney disease and/or renal complications in patients with IBD/the general … Inflammatory Bowel Disease (IBD) Research Registry NCT04243525n/a1 site📍 Pittsburgh University of Pittsburgh Non-nutritive Sweeteners in Inflammatory Bowel Disease NCT07769437NA3 sites📍 Chagrin Falls📍 Cleveland📍 Westlake University Hospitals Cleveland Medical Center · Tests: Sucralose (non-nutritive sweetener) Impact of IBD Activity on Frailty in Patients Over 60 Years NCT06844318n/a34 sites📍 Vitoria-Gasteiz📍 Badalona📍 L'Hospitalet de Llobregat Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis U… Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease NCT07181525n/a1 site📍 Beijing Peking University First Hospital · Tests: anti-cytokine antibodies, anti-integrin antibodies A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2303 in Healthy Adult NCT07199270Phase 11 site📍 Beijing Genrix (Shanghai) Biopharmaceutical Co., Ltd. · Tests: GR2303 injection, Placebo, GR2303 injection, Placebo 68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease NCT07273188EARLY Phase 11 site📍 Rochester Mayo Clinic · Tests: Ga68-FAPI-46 A Prospective Cohort Study Evaluating the Efficacy and Safety of Guselkumab (GUS) With JAK Inhibitors in Patients With Difficult-To-Treat Inflammatory Bowel Disease (IBD) NCT07487311n/a1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: guselkumab (GUS), JAK inhibitors (such as upadacitinib/tofacitinib) Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease NCT07694674n/a1 site📍 Shanghai Shanghai 10th People's Hospital · Tests: Infliximab, Adalimumab, Vedolizumab, Ustekinumab (UST)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy